KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non-Current Assets (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Non-Current Assets for 15 consecutive years, with $808.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 18.54% to $808.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 billion, a 2.38% increase, with the full-year FY2025 number at $808.5 million, up 18.54% from a year prior.
  • Non-Current Assets was $808.5 million for Q4 2025 at Supernus Pharmaceuticals, down from $825.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.1 billion in Q4 2021 to a low of -$568.5 million in Q1 2022.
  • A 5-year average of $776.7 million and a median of $830.8 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: crashed 161.7% in 2022, then skyrocketed 259.8% in 2023.
  • Supernus Pharmaceuticals' Non-Current Assets stood at $1.1 billion in 2021, then dropped by 10.96% to $968.4 million in 2022, then dropped by 18.98% to $784.6 million in 2023, then dropped by 13.07% to $682.0 million in 2024, then increased by 18.54% to $808.5 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Non-Current Assets are $808.5 million (Q4 2025), $825.9 million (Q3 2025), and $643.5 million (Q2 2025).